Cargando…
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels
Alzheimer’s disease (AD) is characterized by irreversible and progressive loss of memory and cognition and profound neuronal loss. Current therapeutic strategies for the treatment of AD have been directed to a variety of targets with the aim of reversing or preventing the disease but, unfortunately,...
Autores principales: | Sozio, Piera, Marinelli, Lisa, Cacciatore, Ivana, Fontana, Antonella, Türkez, Hasan, Giorgioni, Gianfabio, Ambrosini, Dario, Barbato, Francesco, Grumetto, Lucia, Pacella, Stephanie, Cataldi, Amelia, Stefano, Antonio Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270570/ https://www.ncbi.nlm.nih.gov/pubmed/24005968 http://dx.doi.org/10.3390/molecules180910747 |
Ejemplares similares
-
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease
por: Cacciatore, Ivana, et al.
Publicado: (2016) -
Histidyl-Proline Diketopiperazine Isomers as Multipotent Anti-Alzheimer Drug Candidates
por: Turkez, Hasan, et al.
Publicado: (2020) -
Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity
por: Aydin, Nursah, et al.
Publicado: (2022) -
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease
por: Bello, Fabio Del, et al.
Publicado: (2019) -
Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice
por: Kukar, Thomas, et al.
Publicado: (2007)